ADC TOXICITY ATLAS
Payloads & linkers
Payload · Auristatin

ZD02044 (zovodotin)

Tubulin inhibitor (microtubule polymerization inhibitor)

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)NS(=O)(=O)C2=CC=C(C=C2)N)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C
Physicochemistry

Properties

MW
753 Da
XLogP3
3.7
logD₇.₄
-
TPSA
189 Ų
pKa
-
Charge pH 7.4
0
H-bond donors
3
H-bond acceptors
10
Bystander
-
PubChem CID
118203543
Bioactivity
ADC cytotoxicity IC50 = 56 pmol/L (95% CI 48-65) in TF-expressing A431 cells; in vivo, XB002 produced complete tumor regressions in cervical and head/neck cancer PDX models with durable responses at a single 10 mg/kg dose. Payload ZD02044 is a tubulin-polymerization inhibitor (mi
2 agents

ADCs built on this payload

Agent · target
Ocular
Hepatic
Neutrop.
Thrombo.
Anemia
GI
ILD
Neuro.
Zanidatamab zovodotin (ZW49)ERBB2
45
29
0
XB-002 (Samatatug zovodotin)F3
42
0%severity100%
0
Assessed · clear
true 0%
No data
never assessed